Greta Forlani

Varese, 21100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

The HTLV-1 HBZ Oncoprotein and Its Role in Adult T-Cell Leukemia/Lymphoma.

The HTLV-1 HBZ Oncoprotein and Its Role in Adult T-Cell Leukemia/Lymphoma.

Journal: Cancers

Published: June 09, 2026

HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL.

HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL.

Journal: Tumour virus research

Published: March 17, 2026

New concepts for glioblastoma vaccine immunotherapy.

New concepts for glioblastoma vaccine immunotherapy.

Journal: Biomedical journal

Published: January 05, 2026

CIITA-modified glioblastomas vaccinate and induce cross-protection against heterologous wild-type glioblastomas.

CIITA-modified glioblastomas vaccinate and induce cross-protection against heterologous wild-type glioblastomas.

Journal: Journal of translational medicine

Published: April 30, 2025

T Cell Responses to BA.2.86 and JN.1 SARS-CoV-2 Variants in Elderly Subjects.

T Cell Responses to BA.2.86 and JN.1 SARS-CoV-2 Variants in Elderly Subjects.

Journal: Vaccines

Published: November 14, 2024

An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma.

An oncolytic HSV-1 vector induces a therapeutic adaptive immune response against glioblastoma.

Journal: Journal of translational medicine

Published: August 01, 2024

A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells.

A Truncated Isoform of Cyclin T1 Could Contribute to the Non-Permissive HIV-1 Phenotype of U937 Promonocytic Cells.

Journal: Viruses

Published: June 11, 2024

Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma.

Novel vaccination strategies based on optimal stimulation of CD4+ T helper cells for the treatment of oral squamous cell carcinoma.

Journal: Frontiers in immunology

Published: February 18, 2024

Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly.

Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly.

Journal: International journal of molecular sciences

Published: August 04, 2023

The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy.

The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy.

Journal: Biomedical journal

Published: June 21, 2023

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA.

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA.

Journal: Frontiers in immunology

Published: December 28, 2022

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine.

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine.

Journal: EBioMedicine

Published: June 07, 2022

Showing 1-12 of 44

Last Updated: 09/26/2026